According to Aker BioMarine's latest financial reports the company has HK$0.11 Billion in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | HK$0.19 B | 20.9% |
2022-12-31 | HK$0.16 B | 131.23% |
2021-12-31 | HK$70.95 M | 0.65% |
2020-12-31 | HK$70.49 M | -27.15% |
2019-12-31 | HK$96.76 M | 709.77% |
2018-12-31 | HK$11.94 M | |
2012-12-31 | HK$6.94 M | 145.04% |
2011-12-31 | HK$2.83 M | -85.04% |
2010-12-31 | HK$18.94 M | 922.74% |
2009-12-31 | HK$1.85 M | -94.71% |
2008-12-31 | HK$35.02 M | -61.93% |
2007-12-31 | HK$91.99 M |